These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4951970)

  • 41. [The mixed gonadal dysgenesis. Diagnostic criteria and surgical treatment].
    Blanco JA; Martínez-Mora J; Granada M; Toran N; Isnard RM; Castellví A; Casasa JM
    Cir Pediatr; 1997 Jan; 10(1):34-7. PubMed ID: 9131963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Constitutional delay of growth and puberty].
    Cavallo L; Acquafredda A; Zecchino C; Delvecchio M
    Minerva Pediatr; 2001 Oct; 53(5):423-5. PubMed ID: 11668263
    [No Abstract]   [Full Text] [Related]  

  • 43. American Academy of Pediatrics. Committee on Drugs. Counseling and synthetic steroids in short stature without organic disease.
    Pediatrics; 1974 Feb; 53(2):285-7. PubMed ID: 4812018
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of estrogens on gonadotropins and growth hormone secretion in Turner's syndrome and pure gonadal dysgenesis.
    Zarzycki J; Pawlikowska-Haddal A; Hilczer M; Nalewajek H
    Endokrynol Pol; 1989; 40(5):235-9. PubMed ID: 2641512
    [No Abstract]   [Full Text] [Related]  

  • 45. Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy.
    Cuttler L; Van Vliet G; Conte FA; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1087-92. PubMed ID: 4039732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients.
    Guillory AN; Herndon DN; Silva MB; Andersen CR; Suman OE; Finnerty CC
    J Burn Care Res; 2017; 38(4):243-250. PubMed ID: 28240622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Growth in puberty].
    Bierich JR
    Padiatr Padol; 1985; 20(1):7-19. PubMed ID: 4038797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of long-term oxandrolone administration in severely burned children.
    Murphy KD; Thomas S; Mlcak RP; Chinkes DL; Klein GL; Herndon DN
    Surgery; 2004 Aug; 136(2):219-24. PubMed ID: 15300183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coexistence of gonadal dysgenesis and uterine aplasia. A case report.
    Alper MM; Garner PR; Spence JE
    J Reprod Med; 1985 Mar; 30(3):232-4. PubMed ID: 3158739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children.
    Thomas S; Wolf SE; Murphy KD; Chinkes DL; Herndon DN
    J Trauma; 2004 Jan; 56(1):37-44. PubMed ID: 14749563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate.
    Albanese A; Kewley GD; Long A; Pearl KN; Robins DG; Stanhope R
    Arch Dis Child; 1994 Oct; 71(4):315-7. PubMed ID: 7979523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Growth hormone treatment in short stature of unknown origin].
    Wit JM
    Tijdschr Kindergeneeskd; 1992 Oct; 60(5):164-72. PubMed ID: 1448806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of torsion of a mucinous cystadenoma in triple-X syndrome with pure gonadal dysgenesis.
    Lee JH; Kim KS; Cho YG
    Arch Gynecol Obstet; 2006 Jun; 274(3):174-7. PubMed ID: 16408186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Growth and skeletal age of girls with gonadal dysgenesis treated with oxandrolone and sex steroids].
    Rybakowa M; Sołtysik-Wilk E; Piatkowska E; Surówka K
    Folia Med Cracov; 1986; 27(3-4):119-27. PubMed ID: 3570085
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of oxandrolone on body height and skeletal maturation in some growth disorders in children].
    Rybakowa M; Król W; Krzyzanowska T
    Pediatr Pol; 1975 Jun; 50(6):735-43. PubMed ID: 1134870
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of constitutional developmental retardation with oxandrolone].
    Novoa Mogollón J; Salto Hernández L; Pérez Pérez C; Alcáñiz Ferrando J; Uriarte Arana A; Moreno Puertas C; Barceló Lucerga B
    Rev Clin Esp; 1981 Sep; 162(6):259-62. PubMed ID: 7330320
    [No Abstract]   [Full Text] [Related]  

  • 58. [Turner's syndrome: a revolution].
    Rochiccioli P; Tauber MT
    Arch Fr Pediatr; 1992 Mar; 49(3):153-5. PubMed ID: 1610268
    [No Abstract]   [Full Text] [Related]  

  • 59. Oxandrolone therapy in stunting and in ovarian dysgenesis.
    Danowski TS; Weir TF; Girdany B; Lee FA
    Clin Pharmacol Ther; 1967; 8(4):548-53. PubMed ID: 4951970
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.